Related Experiment Videos
Decrease of interleukin-10-producing T cells in the peripheral blood of severe unstable atopic asthmatics
Koichiro Matsumoto1, Hiromasa Inoue, Satoru Fukuyama
1Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. koichi@kokyu.med.kyushu-u.ac.jp
International Archives of Allergy and Immunology
|June 19, 2004
Summary
Interleukin-10 (IL-10) producing CD4+ T cells are reduced in severe unstable asthma. This decrease in IL-10 production in asthma patients is independent of high-dose corticosteroid treatment.
Area of Science:
- Immunology
- Respiratory Medicine
- Cell Biology
Background:
- Interleukin-10 (IL-10) is a key immunoregulatory cytokine produced by various immune cells, including T cells.
- The precise role and profile of IL-10 in atopic asthma, particularly concerning clinical severity, remain incompletely understood.
Purpose of the Study:
- To investigate the profiles of IL-10 production in circulating CD4+ T cells of atopic asthmatics.
- To correlate IL-10 production levels with different clinical severity of asthma.
Main Methods:
- Forty atopic asthmatic patients were stratified into mild, severe stable, and severe unstable groups.
- Peripheral blood and sputum eosinophil counts, and exhaled nitric oxide levels were assessed.
- Peripheral blood mononuclear cells (PBMCs) were stimulated and analyzed for IL-10-producing CD4+ cells via flow cytometry.
Main Results:
- No significant differences in eosinophil counts or nitric oxide levels were observed across the severity groups.
- IL-10-producing CD4+ cells were predominantly found within the CD45RO+ memory T cell population.
- A significantly lower frequency of IL-10-producing CD4+ cells was detected in severe unstable asthmatics compared to both mild and severe stable asthmatics, even with similar high-dose inhaled corticosteroid treatment.
Conclusions:
- Peripheral blood IL-10-producing CD4+CD45RO+ cells are diminished in patients with severe unstable atopic asthma.
- This reduction in IL-10-producing cells is not attributable to the effects of high-dose inhaled corticosteroid therapy.